<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:psc="http://podlove.org/simple-chapters" xmlns:podcast="https://podcastindex.org/namespace/1.0"><channel><title><![CDATA[The Signal: AI in Drug Discovery]]></title><description><![CDATA[<p>The Signal is a podcast for scientists, builders, and leaders working at the frontier of AI and drug discovery. Every episode cuts through the hype to find what's actually working, what's real, and where the field is genuinely headed. Hosted by Alex Temple, founder of Insilico Search Partners — conversations that belong on the record.</p>]]></description><link>www.insilicosearch.com</link><generator>Riverside.fm (https://riverside.com)</generator><lastBuildDate>Wed, 15 Jul 2026 02:27:03 GMT</lastBuildDate><atom:link href="https://api.riverside.com/hosting/9NdAw4HP.rss" rel="self" type="application/rss+xml"/><author><![CDATA[Alex Temple]]></author><pubDate>Tue, 19 May 2026 18:46:10 GMT</pubDate><copyright><![CDATA[2026 Alex Temple]]></copyright><language><![CDATA[en]]></language><ttl>60</ttl><category><![CDATA[Technology]]></category><category><![CDATA[Science]]></category><itunes:author>Alex Temple</itunes:author><itunes:summary>&lt;p&gt;The Signal is a podcast for scientists, builders, and leaders working at the frontier of AI and drug discovery. Every episode cuts through the hype to find what&apos;s actually working, what&apos;s real, and where the field is genuinely headed. Hosted by Alex Temple, founder of Insilico Search Partners — conversations that belong on the record.&lt;/p&gt;</itunes:summary><itunes:type>episodic</itunes:type><itunes:owner><itunes:name>Alex Temple</itunes:name><itunes:email>alex@insilicosearch.com</itunes:email></itunes:owner><itunes:explicit>no</itunes:explicit><itunes:category text="Technology"/><itunes:category text="Science"/><itunes:image href="https://hosting-media.riverside.com/media/podcasts/6731c029-3fe2-4a1f-95e3-b170b61ceead/logos/a073973a-6db3-4e4b-91da-6bcc1fb6915a.jpeg"/><item><title><![CDATA[Ep. 1 - Iain McFadyen]]></title><description><![CDATA[<p><b>Episode 1 — Iain McFadyen</b> Iain built the first ML/AI capability at Moderna from the ground up and has since served as Chief Data Science Officer at LifeMine Therapeutics and Tessera Therapeutics, leading unified computational and digital functions of over 50 people. Today he advises early stage biotechs as a fractional Chief AI Officer. In this conversation Iain breaks down where AI in drug discovery is actually delivering, why most companies are building their teams in the wrong order, and what every founder needs to know before hiring their first computational scientist.</p>]]></description><guid isPermaLink="false">3d8a2152-bd7f-4745-a05d-d56348896ac8</guid><dc:creator><![CDATA[Alex Temple]]></dc:creator><pubDate>Tue, 19 May 2026 18:48:26 GMT</pubDate><enclosure url="https://api.riverside.com/hosting-analytics/media/c676d4966e7203c46936de69c540b22b3fb9da54c8e6ae67f517842b8836423b/eyJlcGlzb2RlSWQiOiIzZDhhMjE1Mi1iZDdmLTQ3NDUtYTA1ZC1kNTYzNDg4OTZhYzgiLCJwb2RjYXN0SWQiOiI2NzMxYzAyOS0zZmUyLTRhMWYtOTVlMy1iMTcwYjYxY2VlYWQiLCJhY2NvdW50SWQiOiI2OWVmOTQwZmNlMjdjMDJmZTZmZGEyNmYiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwYzkyOWY2Yjg3YmY5MjIxYzRiY2Y4L2FsZXgtdGVtcGxlcy1zdHVkaW8tY0ZNS0wtY29tcG9zZXItMjAyNi01LTE5X18xOC00MS0zLm1wMyJ9.mp3" length="69683139" type="audio/mpeg"/><podcast:transcript url="https://hosting-media.riverside.com/media/podcasts/6731c029-3fe2-4a1f-95e3-b170b61ceead/episodes/3d8a2152-bd7f-4745-a05d-d56348896ac8/transcripts.txt" type="text/plain"/><itunes:summary>&lt;p&gt;&lt;b&gt;Episode 1 — Iain McFadyen&lt;/b&gt; Iain built the first ML/AI capability at Moderna from the ground up and has since served as Chief Data Science Officer at LifeMine Therapeutics and Tessera Therapeutics, leading unified computational and digital functions of over 50 people. Today he advises early stage biotechs as a fractional Chief AI Officer. In this conversation Iain breaks down where AI in drug discovery is actually delivering, why most companies are building their teams in the wrong order, and what every founder needs to know before hiring their first computational scientist.&lt;/p&gt;</itunes:summary><itunes:explicit>no</itunes:explicit><itunes:duration>00:37:39</itunes:duration><itunes:image href="https://hosting-media.riverside.com/media/podcasts/6731c029-3fe2-4a1f-95e3-b170b61ceead/logos/a073973a-6db3-4e4b-91da-6bcc1fb6915a.jpeg"/><itunes:season>1</itunes:season><itunes:episode>1</itunes:episode><itunes:title>Ep. 1 - Iain McFadyen</itunes:title><itunes:episodeType>full</itunes:episodeType></item></channel></rss>